BR112012007399A2 - composição de cuidado oral, usos da interleucina-1 recombinante humana e métodos para reduzir o mau hálito e para o tratamento ou prevenção de doença periodontal. - Google Patents
composição de cuidado oral, usos da interleucina-1 recombinante humana e métodos para reduzir o mau hálito e para o tratamento ou prevenção de doença periodontal.Info
- Publication number
- BR112012007399A2 BR112012007399A2 BR112012007399A BR112012007399A BR112012007399A2 BR 112012007399 A2 BR112012007399 A2 BR 112012007399A2 BR 112012007399 A BR112012007399 A BR 112012007399A BR 112012007399 A BR112012007399 A BR 112012007399A BR 112012007399 A2 BR112012007399 A2 BR 112012007399A2
- Authority
- BR
- Brazil
- Prior art keywords
- human recombinant
- methods
- oral care
- periodontal disease
- bad breath
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
composição de cuidado oral, usos da interleucina-1 recombinante humana e métodos para reduzir o mau hálito e para o tratamento ou prevenção de doença periodontal. a presente invenção relaciona-se com composições de cuidado oraisl compreendendo interleucina-1 recombinante humana e métodos das mesmas para manter a cavidade oral numa boa condição, reduzindo o mau hálito e/ou prevenindo ou tratando doenças periodontais. de preferência, a interleucina-1 recombinante humana é a interleucina-1 alfa ou beta recombinante humana.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2009/062639 WO2011038754A1 (en) | 2009-09-29 | 2009-09-29 | Oral care compositions containing human recombinant interleukin-1 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012007399A2 true BR112012007399A2 (pt) | 2016-08-09 |
Family
ID=42715271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012007399A BR112012007399A2 (pt) | 2009-09-29 | 2009-09-29 | composição de cuidado oral, usos da interleucina-1 recombinante humana e métodos para reduzir o mau hálito e para o tratamento ou prevenção de doença periodontal. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20120219511A1 (pt) |
EP (1) | EP2464330B1 (pt) |
JP (1) | JP5661777B2 (pt) |
KR (1) | KR101533316B1 (pt) |
CN (1) | CN102573788B (pt) |
BR (1) | BR112012007399A2 (pt) |
EA (1) | EA019332B1 (pt) |
TW (1) | TWI478722B (pt) |
UA (1) | UA101459C2 (pt) |
WO (1) | WO2011038754A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9917885B2 (en) * | 2013-07-30 | 2018-03-13 | International Business Machines Corporation | Managing transactional data for high use databases |
KR101610861B1 (ko) * | 2014-07-28 | 2016-04-11 | (주)케어젠 | 골분화 촉진능 및 치주인대섬유모세포 활성 촉진능을 갖는 펩타이드 및 이의 용도 |
WO2017172955A1 (en) * | 2016-03-29 | 2017-10-05 | Safewhite, Inc. | Polyelectrolyte dental adhesives for whitening teeth and teeth components |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3683186D1 (de) * | 1985-04-25 | 1992-02-13 | Hoffmann La Roche | Rekombinantes humaninterleukin-1. |
US4801686A (en) * | 1986-09-04 | 1989-01-31 | Immunex Corporation | Purification of recombinant interleukin-1 |
EP0393140B1 (en) * | 1987-12-18 | 1993-08-11 | Immunex Corporation | Topical wound-healing preparations comprising interleukin-1 proteins |
US5202118A (en) * | 1987-12-18 | 1993-04-13 | Immunex Corporation | Method for promoting wound healing using IL-1 |
ZA89202B (en) * | 1988-01-15 | 1989-09-27 | Hoffmann La Roche | Recombinant human interleukin-1 alpha polypeptides |
KR960008010B1 (ko) * | 1988-07-29 | 1996-06-19 | 오오쓰까세이야꾸 가부시끼가이샤 | IL-1α 유도체 및 혈소판 감소증 치료 약제 |
US5827534A (en) * | 1995-05-24 | 1998-10-27 | University Of Maryland At Baltimore | Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery |
US6413760B1 (en) * | 1997-04-15 | 2002-07-02 | Genetics Institute, Inc. | Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof |
ID20480A (id) * | 1997-10-02 | 1998-12-24 | Lg Chemical Ltd | Komposisi untuk mencegah atau mengobati penyakit periodontal yang terdiri dari ekstrak dari achyranthis radix atau ulmus cortex |
US8283135B2 (en) * | 2000-06-30 | 2012-10-09 | The Procter & Gamble Company | Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
JP2002200161A (ja) * | 2000-10-24 | 2002-07-16 | Menicon Co Ltd | 培養皮膚代替物の製造方法およびそれにより得られる培養皮膚代替物 |
US20030105027A1 (en) * | 2001-11-06 | 2003-06-05 | Rosenbloom Richard A. | Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
EP1680064A1 (en) * | 2003-09-18 | 2006-07-19 | Smithkline Beecham Corporation | Method of applying oral compositions |
ATE433746T1 (de) * | 2004-03-12 | 2009-07-15 | Biodel Inc | Insulinzusammensetzungen mit verbesserter wirkstoffabsorption |
DE602005025111D1 (de) * | 2004-05-03 | 2011-01-13 | Interleukin Genetics Inc | Diagnostika und therapeutika für mit einem entzündlichen il-1-haplotyp assoziierte krankheiten |
JP2008511652A (ja) * | 2004-08-27 | 2008-04-17 | アドヴァンスド ヴァイラル リサーチ コーポレーション | 創傷治癒の促進方法 |
US20080008663A1 (en) * | 2006-07-10 | 2008-01-10 | Wm. Wrigley Jr. Company | Method of reducing inflammation |
GB0619786D0 (en) * | 2006-10-06 | 2006-11-15 | Inst Of Technology Sligo | An antimicrobial and immunostimulatory system |
-
2009
- 2009-09-29 EA EA201200196A patent/EA019332B1/ru not_active IP Right Cessation
- 2009-09-29 CN CN200980161579.7A patent/CN102573788B/zh active Active
- 2009-09-29 BR BR112012007399A patent/BR112012007399A2/pt not_active IP Right Cessation
- 2009-09-29 KR KR1020127008138A patent/KR101533316B1/ko active IP Right Grant
- 2009-09-29 US US13/395,688 patent/US20120219511A1/en not_active Abandoned
- 2009-09-29 WO PCT/EP2009/062639 patent/WO2011038754A1/en active Application Filing
- 2009-09-29 EP EP09736580.3A patent/EP2464330B1/en active Active
- 2009-09-29 UA UAA201205107A patent/UA101459C2/uk unknown
- 2009-09-29 JP JP2012531243A patent/JP5661777B2/ja not_active Expired - Fee Related
-
2010
- 2010-09-28 TW TW099132770A patent/TWI478722B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN102573788B (zh) | 2014-05-21 |
EA201200196A1 (ru) | 2012-07-30 |
KR20120081593A (ko) | 2012-07-19 |
CN102573788A (zh) | 2012-07-11 |
KR101533316B1 (ko) | 2015-07-03 |
EP2464330B1 (en) | 2016-03-23 |
TWI478722B (zh) | 2015-04-01 |
EP2464330A1 (en) | 2012-06-20 |
WO2011038754A1 (en) | 2011-04-07 |
EA019332B1 (ru) | 2014-02-28 |
UA101459C2 (uk) | 2013-03-25 |
JP5661777B2 (ja) | 2015-01-28 |
TW201117823A (en) | 2011-06-01 |
JP2013505972A (ja) | 2013-02-21 |
US20120219511A1 (en) | 2012-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012013473A2 (pt) | composição para higiene oral e método para o tratamento de uma doença ou condição do tecido mole da cavidade oral | |
BR112013026032A2 (pt) | composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida | |
ATE551063T1 (de) | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen | |
BRPI0921002A8 (pt) | Composições para tratamento bucal compreendendo sílica fundida e seu uso | |
BR112016007010A2 (pt) | composição de higiene oral anidro e método de fabricação de uma mistura de tratamento | |
BRPI0925036B8 (pt) | uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele | |
BRPI0912411B8 (pt) | uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune | |
IL214462A0 (en) | Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions | |
BR112012006891A2 (pt) | formulação de hydrogel compreendendo uma solução aquosa com potencial oxidativo redutivo | |
BR112014031394A2 (pt) | composições e métodos para absorção transmucosa | |
BR112013015859A2 (pt) | composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica | |
BRPI0815203B8 (pt) | composição em gel contendo pirfenidona, e seu processo de fabricação | |
BRPI0907102A2 (pt) | composição dental, e, método para eliminar ou reduzir o desconforto e a dor associados com a hipersensibilidade da dentina | |
BR112014013140A2 (pt) | cosmética de prótese | |
BRPI1012066A2 (pt) | composição para o cuidado oral , e, métodos para preparar a composição para o cuidado oral e para administrar um composto de zinco a um indivíduo animal ou humano em necessidade do mesmo | |
BR112013002232A2 (pt) | formulações de colutório para o uso com o dispositivo de liberação de pasta de dente | |
TOHIDAST et al. | DMFT (Decayed, Missing, Filled, Teeth) Oral health index in sweets and cable industry workers | |
GB202302767D0 (en) | Improvements in or relating to patient care | |
BR112012007399A2 (pt) | composição de cuidado oral, usos da interleucina-1 recombinante humana e métodos para reduzir o mau hálito e para o tratamento ou prevenção de doença periodontal. | |
BRPI0602397C1 (pt) | composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições | |
BR112014008190A2 (pt) | composições para realce da saúde da unha | |
MX367580B (es) | El uso de lapatinib o una sal o composición farmacéuticamente aceptable del mismo para el tratamiento del cáncer. | |
BR112015017546A2 (pt) | composições hemostáticas, usos das mesmas e kit | |
BR112015022279A2 (pt) | composições pigmentadas para tratamento da pele | |
BR112015022265A2 (pt) | composições pigmentadas para tratamento da pele |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: UNITED TECHNOLOGIES UT AG (CH) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |